115 related articles for article (PubMed ID: 7870343)
1. Molecular analysis of C3 allotypes in patients with systemic vasculitis.
Finn JE; Zhang L; Agrawal S; Jayne DR; Oliveira DB; Mathieson PW
Nephrol Dial Transplant; 1994; 9(11):1564-7. PubMed ID: 7870343
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of C3 allotypes related to transplant outcome in human renal allografts.
Andrews PA; Finn JE; Mathieson PW; Sacks SH
Transplantation; 1995 Dec; 60(11):1342-6. PubMed ID: 8525532
[TBL] [Abstract][Full Text] [Related]
3. The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha-chain of the complement component, C3.
Poznansky MC; Clissold PM; Lachmann PJ
J Immunol; 1989 Aug; 143(4):1254-8. PubMed ID: 2473125
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of C3 allotypes in patients with nephritic factor.
Finn JE; Mathieson PW
Clin Exp Immunol; 1993 Mar; 91(3):410-4. PubMed ID: 8443964
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of C3 allotypes in Chinese patients with immunoglobulin A nephropathy.
Finn JE; Li PK; Lai KN; Mathieson PW
Am J Kidney Dis; 1994 Apr; 23(4):543-6. PubMed ID: 8154490
[TBL] [Abstract][Full Text] [Related]
6. C3 alleles in diseases associated with C3 activation.
Welch TR; Berry A
Dis Markers; 1987 Jun; 5(2):81-7. PubMed ID: 3502986
[TBL] [Abstract][Full Text] [Related]
7. Influence of donor C3 allotype on late renal-transplantation outcome.
Brown KM; Kondeatis E; Vaughan RW; Kon SP; Farmer CK; Taylor JD; He X; Johnston A; Horsfield C; Janssen BJ; Gros P; Zhou W; Sacks SH; Sheerin NS
N Engl J Med; 2006 May; 354(19):2014-23. PubMed ID: 16687714
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and inheritance of C3 types in the Polish population.
Schlesinger D; Mańczak M; Hałasa J
Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):277-83. PubMed ID: 444041
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of C3 component of complement in the Polish population. I. Population and family studies.
Mańczak M
Arch Immunol Ther Exp (Warsz); 1984; 32(4):421-30. PubMed ID: 6534316
[TBL] [Abstract][Full Text] [Related]
10. The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha chain of the complement component, C3.
Poznansky MC; Clissold PM; Lachmann PJ
J Immunol; 1989 Dec; 143(11):3860-2. PubMed ID: 2584723
[No Abstract] [Full Text] [Related]
11. Polymorphism of C3 component of complement in the Polish population. II. Rare phenotypes in C3 system.
Mańczak M
Arch Immunol Ther Exp (Warsz); 1985; 33(3):443-52. PubMed ID: 4062509
[TBL] [Abstract][Full Text] [Related]
12. Complement C3 and its polymorphism: biological and clinical consequences.
Delanghe JR; Speeckaert R; Speeckaert MM
Pathology; 2014 Jan; 46(1):1-10. PubMed ID: 24300728
[TBL] [Abstract][Full Text] [Related]
13. Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus.
Miyagawa H; Yamai M; Sakaguchi D; Kiyohara C; Tsukamoto H; Kimoto Y; Nakamura T; Lee JH; Tsai CY; Chiang BL; Shimoda T; Harada M; Tahira T; Hayashi K; Horiuchi T
Rheumatology (Oxford); 2008 Feb; 47(2):158-64. PubMed ID: 18174230
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism in C3 is associated with progression in chronic kidney disease (CKD) patients with IgA nephropathy but not in other causes of CKD.
Ibrahim ST; Chinnadurai R; Ali I; Payne D; Rice GI; Newman WG; Algohary E; Adam AG; Kalra PA
PLoS One; 2020; 15(1):e0228101. PubMed ID: 32004338
[TBL] [Abstract][Full Text] [Related]
15. Complement C3F allotype synthesized by liver recipient modifies transplantation outcome independently from donor hepatic C3.
Valero-Hervás DM; Sánchez-Zapardiel E; Castro MJ; Gallego-Bustos F; Cambra F; Justo I; Laguna-Goya R; Jiménez-Romero C; Moreno E; López-Medrano F; San Juan R; Fernández-Ruiz M; Aguado JM; Paz-Artal E
Clin Transplant; 2017 Jan; 31(1):. PubMed ID: 27801525
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism of C3 in the Veneto population, Italy.
Crestani C; Caenazzo L; Cortivo P; Scorretti C; Caenazzo C
Anthropol Anz; 1989 Dec; 47(4):299-303. PubMed ID: 2629619
[TBL] [Abstract][Full Text] [Related]
17. HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis.
Maksymowych WP; Suarez-Almazor ME; Buenviaje H; Cooper BL; Degeus C; Thompson M; Russell AS
J Rheumatol; 2002 Nov; 29(11):2319-26. PubMed ID: 12415587
[TBL] [Abstract][Full Text] [Related]
18. C3 and C4 allotypes in anti-neutrophil cytoplasmic autoantibody (ANCA)-positive vasculitis.
Persson U; Truedsson L; Westman KW; Segelmark M
Clin Exp Immunol; 1999 May; 116(2):379-82. PubMed ID: 10337034
[TBL] [Abstract][Full Text] [Related]
19. C3F gene mutation is involved in the susceptibility to pre-eclampsia.
Rhim MS; Meddeb S; Kaabia O; Jalloul M; Sakouhi M; Jrzad BB; Felah R
Arch Gynecol Obstet; 2015 May; 291(5):1023-7. PubMed ID: 25322978
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of complement C3 in chronic inflammatory bowel disease. Predominance of the C3F gene in Crohn's disease.
Elmgreen J; Sørensen H; Berkowicz A
Acta Med Scand; 1984; 215(4):375-8. PubMed ID: 6731047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
